Baxter
Baxter Healthcare
Growth, innovation and responsiveness to customers’ needs have helped shaping the Anaesthesia and Critical Care business of Baxter.
With its offerings, Baxter Anaesthesia & Critical Care continues to sustain its commitments as an Anaesthesia Provider. Baxter has made a real commitment to providing pharmaceuticals and services to assist anaesthesia and critical care clinicians worldwide in delivering the highest standard of patient care and real freedom of choice when selecting the right inhalation anaesthetic for each patient. Baxter is the only company to offer all modern inhalation anaesthetics. Our pharmaceutical portfolio includes the inhalation anaesthestics Suprane (desflurane, USP), Sevoflurane Baxter and AErrane (isoflurane, USP) as well as the short-acting intravenous cardio selective beta-blocker Brevibloc (esmolol HCL).
Besides a complete portfolio of inhalation anaesthetics, Baxter is the market leader in disposable infusion pumps with a wide range of products designed for pain management. Baxter offers the Infusor elastomeric infusion pumps in various volumes and flow rates to suit traditional IV treatment, peripheral nerve block and the emerging technique of continuous wound infusion (CWI). Baxter also offers a range of patient control modules for patient controlled analgesia (PCA) and patient controlled epidural analgesia (PCEA) as well as a range of fenestrated catheters for CWI.
Baxter International Inc., through its subsidiaries, assists healthcare professionals and their patients with the treatment of complex medical conditions, including hemophilia, immune disorders, cancer, infectious diseases, kidney disease, trauma and other conditions. The company applies its expertise in medical devices, pharmaceuticals and biotechnology to make a meaningful difference in patients' lives.
Print this page